Windlas Biotech Ltd. (WINDLAS)

Overview

Windlas Biotech Limited is a distinguished contract development and manufacturing organization (CDMO) that specializes in the pharmaceutical sector, serving both the domestic market in India and clients around the globe. Since its inception in 2001, the company has positioned itself as a crucial player in the pharmaceutical manufacturing industry, leveraging its extensive capabilities in product discovery, development, licensing, and commercial manufacturing of generic products. Headquartered in Gurugram, India, Windlas Biotech Limited has forged its reputation through dedicated service and adherence to quality, fulfilling the complex needs of the pharmaceutical and nutraceutical segments.

Products and Services

Windlas Biotech Limited provides a comprehensive suite of services and products tailored to the pharmaceutical and nutraceutical industries. These offerings include:

• CDMO Services: Windlas Biotech specializes in offering complete contract development and manufacturing services that span the entire lifecycle of pharmaceutical products. This includes initial product discovery, advanced product development, strategic licensing agreements, and ultimately, large-scale commercial manufacturing. The focus is on ensuring quality, efficiency, and scalability throughout the process.
• Nutraceutical Supplement Products: Beyond pharmaceuticals, the company extends its manufacturing capabilities to the nutraceutical sector, producing a wide range of supplement products. These are designed to support overall health and wellness, catering to the growing demand for dietary supplements across markets.
• Generic Products Portfolio: Windlas Biotech offers an extensive portfolio of generic products, including:
  • Fixed Dosage Combinations: These are pharmaceutical preparations combining two or more active ingredients in a single dosage form, designed to simplify the medication regimen and enhance patient compliance.
  • Fixed Dosage Plus Modified Release Combinations: This category includes formulations that not only combine active ingredients but also incorporate modified-release technology to optimize the drug's release rate and absorption.
  • Customized Generics: Tailored generic formulations that cater to specific market or therapeutic needs, offering flexibility and targeted solutions for generic medication requirements.
  • Chewable or Dispersible: Formulations designed for ease of administration, particularly beneficial for patients who have difficulty swallowing conventional tablets or capsules.
• Manufacturing Capabilities: The company boasts versatile manufacturing capabilities, including the production of tablets, capsules, pouches, sachets, and liquid bottles. This enables Windlas Biotech to cater to a wide array of pharmaceutical and nutraceutical product requirements, maintaining high standards of quality and compliance.